Background
Ondasetron
Haloperidol
Methods
Statistical analysis
Results
Ondasetron group | Haloperidol group | Statistical Significance | |
---|---|---|---|
Sample Size
| 40 | 40 | n.s |
Gender (Male)
| 27 | 26 | n.s |
Age
| 70.1 ± 9.3 | 70.9 ± 9.9 | n.s |
Type of surgery: CABG
| 34 | 35 | n.s |
Type of surgery: Aortic valve
| 2 | 1 |
P < 0.05 |
Replacement
| |||
Type of surgery CABG and aortic
| 2 | 2 | n.s |
valve replacement combined
| |||
Mitral valve surgery
| 1 | 1 | n.s |
Aortic Surgery
| 1 | 1 | n.s |
Years of Education
| 7.3 ± 0.7 | 7.8 ± 0.7 | n.s. |
Ondasetron group mean rating prior to application | Ondasetron group mean rating after application | Statistical Significance |
---|---|---|
3.1 ± 0.4 | 1.2 ± 0.1 |
p < 0.01 |
Haloperidol group mean rating prior to application
|
Haloperidol group mean rating after application
|
Statistical Significance
|
3.1 ± 0.4 | 1.3 ± 0.1 |
p < 0.01 |
Ondasetron effect on rating(improvement in percentage)
|
Haloperidol effect on rating(improvement in percentage)
|
Statistical significance
|
61.29% | 58.064% | n.s |
Ondasetron patients that remained delirious, n = 7 |
Haloperidol patients that remained delirious, n = 6 | n.s |